Episode 103: A Board Member’s Perspective on Biotech Leadership and Strategy
What do biotech boards want to see in a CEO—and what mistakes can quickly derail a company’s success?
In this episode, host Elaine Hamm, PhD, sits down with Mark Corrigan, MD, one of the most experienced and respected leaders in the biotech industry. From shaping the development of blockbuster drugs to serving as CEO and board member for multiple companies, Mark has a unique perspective on the intersection of science, leadership, and strategy. He shares candid insights on what makes a strong CEO, the role boards should (and shouldn’t) play, and how to navigate today’s tough financing environment without losing sight of the mission.
In this episode, you’ll learn:
- The key qualities that boards value most in biotech CEOs—and the red flags that raise concerns.
- Why humility, adaptability, and a clear value proposition are essential traits for leadership.
- How boards and CEOs can partner effectively when money is tight and timelines are long.
Tune in to gain board-level insights into biotech leadership and decision-making that can help you shape your own path forward.
Links:
Connect with Mark Corrigan, MD, and check out Wave Life Sciences, AstronauTx, Silver Creek Pharmaceuticals,Ceretype Neuromedicine, and Cadenza Bio.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Listen to our previous episode on Building Biotech Boards.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
